All contributors
Onconephrology contributor
Sise, Meghan E
Primarily Anticancer drug nephrotoxicityHonor roll · #29
30
Clinical papers
1,442
Citations (iCite)
2 / 17
First / senior author
2019–2025
Active years
Subfield mix
Clinical papers by onconephrology subfield (a paper can count in more than one).
Anticancer drug nephrotoxicity19
Checkpoint-inhibitor kidney injury16
Onco-nephrology (general)6
Cellular therapy renal effects3
Anti-VEGF / TKI renal effects1
Agents they study
Catalog agents whose clinical kidney literature lists Sise among the leading contributors.
Verify
Representative recent papers, and this author’s full PubMed bibliography.
A code-tallied bibliometric profile from PubMed + NIH iCite, restricted to human/clinical papers (regenerated 2026-07-08). Recognition of published contribution — not a verdict on merit or influence, and not medical advice.